Trials / Terminated
TerminatedNCT01880073
FemVue and Tubal Patency
Use of FemVue for Assessment of Tubal Patency as Compared to Laparoscopic Chromopertubation
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
A thorough infertility evaluation commonly involves determining whether a woman's fallopian tubes are patent. The two most often utilized methods of evaluating the fallopian tubes are hysterosalpingogram (taking an X-ray of the pelvis after injecting dye through the uterus and fallopian tubes) and laparoscopic chromopertubation (a surgical procedure in which dye is visualized passing through the fallopian tubes). The FemVue Saline-Air device is a new method of assessing tubal patency. The device utilizes a mixture of saline and air bubbles that can be seen passing through the fallopian tubes by ultrasound. FemVue can be efficiently performed in a physician's office and is minimally invasive. Unlike hysterosalpingogram and laparoscopic chromopertubation, it does not carry the risks of anesthesia or surgery, and doesn't expose the patient to radiation or contrast. It does, like the other two methods, carry a small risk of infection. This study will involve using the FemVue device on patients under anesthesia in the operating room before they undergo scheduled laparoscopic chromopertubation, the gold standard for evaluating tubal patency. The two methods will be compared to determine the accuracy of the FemVue device.
Detailed description
Subjects who agree to participate will have their tubes evaluated by using the FemVue Saline-Air device and laparoscopic chromopertubation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FemVue device | The device will be used in conjunction with what is now considered the standard of care to determine if it's as effective. |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2016-05-24
- Completion
- 2019-05-24
- First posted
- 2013-06-18
- Last updated
- 2020-05-27
- Results posted
- 2020-05-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01880073. Inclusion in this directory is not an endorsement.